vs

Side-by-side financial comparison of Foghorn Therapeutics Inc. (FHTX) and Research Solutions, Inc. (RSSS). Click either name above to swap in a different company.

Research Solutions, Inc. is the larger business by last-quarter revenue ($11.8M vs $9.2M, roughly 1.3× Foghorn Therapeutics Inc.). Research Solutions, Inc. runs the higher net margin — 4.6% vs -234.3%, a 238.9% gap on every dollar of revenue. On growth, Foghorn Therapeutics Inc. posted the faster year-over-year revenue change (223.8% vs -1.0%). Over the past eight quarters, Foghorn Therapeutics Inc.'s revenue compounded faster (35.3% CAGR vs -1.3%).

Foghorn Therapeutics Inc. is a clinical-stage biotechnology company dedicated to developing novel therapies targeting the chromatin regulatory system to treat various types of cancer and other severe diseases. It advances a diverse pipeline of targeted drug candidates, conducting internal R&D and strategic partnerships to serve global patient populations.

Jacobs Solutions Inc. is an American international technical professional services firm based in Dallas. The company provides engineering, technical, professional, and construction services as well as scientific and specialty consulting for a broad range of clients globally, including companies, organizations, and government agencies. Jacobs has consistently ranked No. 1 on both Engineering News-Record (ENR)'s 2018, 2019, 2020, 2021, 2022, and 2023 Top 500 Design Firms and Trenchless Technolo...

FHTX vs RSSS — Head-to-Head

Bigger by revenue
RSSS
RSSS
1.3× larger
RSSS
$11.8M
$9.2M
FHTX
Growing faster (revenue YoY)
FHTX
FHTX
+224.8% gap
FHTX
223.8%
-1.0%
RSSS
Higher net margin
RSSS
RSSS
238.9% more per $
RSSS
4.6%
-234.3%
FHTX
Faster 2-yr revenue CAGR
FHTX
FHTX
Annualised
FHTX
35.3%
-1.3%
RSSS

Income Statement — Q4 FY2025 vs Q2 FY2026

Metric
FHTX
FHTX
RSSS
RSSS
Revenue
$9.2M
$11.8M
Net Profit
$-21.7M
$546.9K
Gross Margin
52.4%
Operating Margin
-258.2%
6.3%
Net Margin
-234.3%
4.6%
Revenue YoY
223.8%
-1.0%
Net Profit YoY
-11.1%
127.6%
EPS (diluted)
$-0.35
$0.02

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
FHTX
FHTX
RSSS
RSSS
Q4 25
$9.2M
$11.8M
Q3 25
$8.2M
$12.3M
Q2 25
$7.6M
$12.4M
Q1 25
$6.0M
$12.7M
Q4 24
$2.9M
$11.9M
Q3 24
$7.8M
$12.0M
Q2 24
$6.9M
$12.1M
Q1 24
$5.0M
$12.1M
Net Profit
FHTX
FHTX
RSSS
RSSS
Q4 25
$-21.7M
$546.9K
Q3 25
$-15.8M
$749.4K
Q2 25
$-17.9M
$2.4M
Q1 25
$-18.8M
$216.5K
Q4 24
$-19.5M
$-2.0M
Q3 24
$-19.1M
$669.0K
Q2 24
$-23.0M
$-2.8M
Q1 24
$-25.0M
$76.3K
Gross Margin
FHTX
FHTX
RSSS
RSSS
Q4 25
52.4%
Q3 25
50.6%
Q2 25
51.0%
Q1 25
49.5%
Q4 24
48.9%
Q3 24
47.9%
Q2 24
46.5%
Q1 24
45.2%
Operating Margin
FHTX
FHTX
RSSS
RSSS
Q4 25
-258.2%
6.3%
Q3 25
-226.9%
7.8%
Q2 25
-279.2%
9.7%
Q1 25
-385.0%
4.4%
Q4 24
-840.5%
0.8%
Q3 24
-305.5%
5.4%
Q2 24
-386.6%
5.5%
Q1 24
-558.3%
0.7%
Net Margin
FHTX
FHTX
RSSS
RSSS
Q4 25
-234.3%
4.6%
Q3 25
-194.4%
6.1%
Q2 25
-237.3%
19.0%
Q1 25
-316.4%
1.7%
Q4 24
-682.9%
-16.6%
Q3 24
-244.9%
5.6%
Q2 24
-333.6%
-23.3%
Q1 24
-495.4%
0.6%
EPS (diluted)
FHTX
FHTX
RSSS
RSSS
Q4 25
$-0.35
$0.02
Q3 25
$-0.25
$0.02
Q2 25
$-0.28
$0.08
Q1 25
$-0.30
$0.01
Q4 24
$-0.23
$-0.07
Q3 24
$-0.31
$0.02
Q2 24
$-0.45
$-0.09
Q1 24
$-0.59
$0.00

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
FHTX
FHTX
RSSS
RSSS
Cash + ST InvestmentsLiquidity on hand
$80.9M
$12.3M
Total DebtLower is stronger
Stockholders' EquityBook value
$-108.5M
$17.2M
Total Assets
$198.1M
$44.2M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
FHTX
FHTX
RSSS
RSSS
Q4 25
$80.9M
$12.3M
Q3 25
$89.3M
$12.0M
Q2 25
$72.6M
$12.2M
Q1 25
$61.0M
$9.9M
Q4 24
$55.5M
$7.7M
Q3 24
$57.7M
$6.9M
Q2 24
$138.9M
$6.1M
Q1 24
$79.3M
$4.2M
Stockholders' Equity
FHTX
FHTX
RSSS
RSSS
Q4 25
$-108.5M
$17.2M
Q3 25
$-89.7M
$15.6M
Q2 25
$-76.7M
$13.9M
Q1 25
$-61.7M
$11.2M
Q4 24
$-45.5M
$11.1M
Q3 24
$-28.3M
$12.8M
Q2 24
$-14.3M
$11.7M
Q1 24
$-97.5M
$14.1M
Total Assets
FHTX
FHTX
RSSS
RSSS
Q4 25
$198.1M
$44.2M
Q3 25
$205.0M
$45.5M
Q2 25
$226.2M
$46.1M
Q1 25
$258.7M
$45.2M
Q4 24
$284.0M
$42.8M
Q3 24
$308.4M
$41.4M
Q2 24
$328.6M
$41.9M
Q1 24
$255.0M
$40.8M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
FHTX
FHTX
RSSS
RSSS
Operating Cash FlowLast quarter
$-22.3M
$1.4M
Free Cash FlowOCF − Capex
$1.4M
FCF MarginFCF / Revenue
11.7%
Capex IntensityCapex / Revenue
0.0%
0.1%
Cash ConversionOCF / Net Profit
2.53×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
FHTX
FHTX
RSSS
RSSS
Q4 25
$-22.3M
$1.4M
Q3 25
$-18.9M
$1.1M
Q2 25
$-21.0M
$2.3M
Q1 25
$-24.0M
$2.9M
Q4 24
$-24.5M
$1.0M
Q3 24
$-21.0M
$843.1K
Q2 24
$-25.5M
$2.0M
Q1 24
$-29.3M
$2.0M
Free Cash Flow
FHTX
FHTX
RSSS
RSSS
Q4 25
$1.4M
Q3 25
$1.1M
Q2 25
$-21.0M
Q1 25
$-24.0M
$2.9M
Q4 24
$-25.0M
Q3 24
$-21.3M
Q2 24
$-25.6M
$1.9M
Q1 24
$-29.4M
$2.0M
FCF Margin
FHTX
FHTX
RSSS
RSSS
Q4 25
11.7%
Q3 25
8.8%
Q2 25
-278.2%
Q1 25
-403.2%
22.8%
Q4 24
-875.3%
Q3 24
-273.0%
Q2 24
-371.0%
16.0%
Q1 24
-583.1%
16.6%
Capex Intensity
FHTX
FHTX
RSSS
RSSS
Q4 25
0.0%
0.1%
Q3 25
0.0%
0.1%
Q2 25
0.3%
Q1 25
0.5%
0.0%
Q4 24
16.8%
Q3 24
4.0%
Q2 24
0.2%
0.1%
Q1 24
2.0%
0.0%
Cash Conversion
FHTX
FHTX
RSSS
RSSS
Q4 25
2.53×
Q3 25
1.48×
Q2 25
0.96×
Q1 25
13.36×
Q4 24
Q3 24
1.26×
Q2 24
Q1 24
26.43×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

FHTX
FHTX

Segment breakdown not available.

RSSS
RSSS

Transactions$6.6M56%
Platforms$5.2M44%

Related Comparisons